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Many of the similarity-based virtual screening approaches assume that molecular fragments that are not related to the biological
activity carry the same weight as the important ones. This was the reason that led to the use of Bayesian networks as an alternative
to existing tools for similarity-based virtual screening. In our recent work, the retrieval performance of the Bayesian inference
network (BIN) was observed to improve signiﬁcantly when molecular fragments were reweighted using the relevance feedback
information. In this paper, a set of active reference structures were used to reweight the fragments in the reference structure. In this
approach,higherweightswereassignedtothosefragmentsthatoccurmorefrequentlyinthesetofactivereferencestructureswhile
others were penalized. Simulated virtual screening experiments with MDL Drug Data Report datasets showed that the proposed
approach signiﬁcantly improved the retrieval eﬀectiveness of ligand-based virtual screening, especially when the active molecules
being sought had a high degree of structural heterogeneity.
1.Introduction
Virtual screening refers to the use of a computer-based
method to process compounds from a library or database
of compounds in order to identify and select ones that are
likely to possess a desired biological activity, such as the
ability to inhibit the action of a particular therapeutic target.
Theselectionofmoleculeswithavirtualscreeningalgorithm
should yield a higher proportion of active compounds, as
assessed by experiment, relative to a random selection of the
same number of molecules [1].
Over recent decades, drug discovery companies have
used combinatorial chemistry approaches to create large
and diverse libraries of structures; therefore large arrays
of compounds are formed by combining sets of diﬀerent
types of reagents, called building blocks, in a systematic
and repetitive way. These libraries can be used as a
source of new potential drugs, since the compounds in
the libraries can be randomly tested or screened to ﬁnd
good drug compounds. Increasing the capabilities of testing
compounds using chemoinformatic technologies such as
high-throughputscreening(HTS)enableshundredsofthou-
sands of these compounds to be tested in a short time. Com-
puters can be used to aid this process in a number of ways;
for example, in the creation of virtual combinatorial libraries
which can be much larger than their real counterparts. There
are two methods for screening those libraries, looking into
active sites of interest and looking for similarities to a known
activecompound.Recently,searchingchemicaldatabaseshas
been done using computers instead of experiment, and this
is known as the virtual screening technique [2–9].
Chemical information systems oﬀer three principal types
of searching facility. Early systems provided two types of
retrieval mechanisms: structure searching and substructure
searching. These mechanisms were later complemented by
another access mechanism: similarity searching. There are
many studies in the literature associated with the measure-
ment of molecular similarity [10–13]. However, the most
common approaches are based on 2D ﬁngerprints, with
the similarity between a reference structure and a database
structure computed using association coeﬃcients such as the
Tanimoto coeﬃcient [1, 14].2 The Scientiﬁc World Journal
Several methods have been used to further optimise
the measures of similarity between molecules, including
weighting, standardization, and data fusion [15–18].
The Bayesian inference network (BIN) was originally
developed for text document retrieval systems [19]. Many
studies in information retrieval (IR) have shown that the
retrieval eﬀectiveness of BIN can be improved by fragment
reweighting. Fragments reweighting is one of the most useful
query modiﬁcation techniques in IR systems [20–22]. In
our previous works, the retrieval performance of Bayesian
inference network was observed to improve signiﬁcantly
when relevance feedback and turbo search screening were
used [23].
In this paper, we enhanced the screening eﬀectiveness of
BIN using a weighting factor. In this approach, weighting
factors are calculated for each fragment of the multireference
input query based on the frequency of their occurrence in
the set of references’ input. This weighting factor is later used
to calculate a new weight for each fragment of the reference
structure.
2.MaterialandMethods
This study has compared the retrieval results obtained
using three diﬀerent similarity-based screening models. The
ﬁrst screening system was based on the tanimoto (TAN)
coeﬃcient, which has been used in ligand-based virtual
screening for many years and is now considered a reference
standard. The second model was based on a basic BIN [24]
using the Okapi (OKA) weight, which was found to perform
the best in their experiments and which we shall refer to as
the conventional BIN model. The third model, our proposed
model, is a BIN based on reweighted fragments, which we
shall refer to as the BINRF model. In what follows, we give a
brief description of each of these three models.
2.1. Tanimoto-Based Similarity Model. This model used
the continuous form of the tanimoto coeﬃcient, which
is applicable to nonbinary data of ﬁngerprint. SK,L is the
similarity between objects or molecules K and L, which,
using tanimoto, is given by (1):
SkL =
M
j=1wjkwjl
M
j=1

wjk
2
+
M
j=1

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2
−
M
j=1

wkwjl
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For molecules described by continuous variables, the
molecular space is deﬁned by an M × N matrix, where entry
wji is the value of the jth fragments (1 ≤ j ≤ M) in the ith
molecule (1 ≤ i ≤ N). The origins of this coeﬃcient can be
found in a review paper by Ellis et al. [25].
2.2. Conventional BIN Model. The conventional BIN model,
as shown in Figure 1, is used in molecular similarity
searching. It consists of three types of nodes: compound
nodes as roots, fragment nodes, and a reference structure
node as leaf. The roots of the network are the nodes without
parent nodes and the leaves are the nodes without child
nodes.Eachcompoundnoderepresentsanactualcompound
c1
f1 f2 fi fn
Compound
 nodes
Reference
 nodes
Fragment
 nodes
cj cm
r
Figure 1: Bayesian inference network model.
in the collection and has one or more fragment nodes as
children. Each fragment node has one or more compound
nodes as parents and one reference structure node as a child
(or more where multiple references are used). Each network
node is a binary value, taking one of the two values from the
set {true, false}. The probability that the reference structure
is satisﬁed given a particular compound is obtained by
computing the probabilities associated with each fragment
node connected to the reference structure node. This process
is repeated for all the compounds in the database.
The resulting probability scores are used to rank the
database in response to a bioactive reference structure in the
order of decreasing probability of similar bioactivity to the
reference structure.
To estimate the probability associating each compound
to the reference structure, the probability for the fragment
andreferencenodesmustbecomputed.Oneparticularbelief
function, called OKA, has been found to have the most
eﬀective recall [24]. This function was used to compute the
probabilities for the fragment nodes and is given by (2):
belOKA
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where α = Constant; and experiments using the BIN show
that the best value is 0.4 [26, 27], ﬀij = frequency of the
ith fragment within the jth compound reference structure,
cfi = number of compounds containing the ith fragment,
|cj |= the size (in terms of number of fragments) of the jth
compound, |Cavg| = the average size of all the compounds in
the database, and m = the total number of compounds.
To produce a ranking of the compounds in the col-
lection with respect to a given reference structure, a belief
function from In Query, the SUM operator, was used. If
p1, p2,..., pn represent the belief in the fragment nodes
(parent nodes of r), then the belief at r is given by (3):
belsum(r) =
n
i=1 pi
n
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Table 1: MDDR activity classes for DS1 dataset.
Activity
index Activity class Active
molecules
Pairwise
similarity
(mean)
31420 Renin inhibitors 1130 0.290
71523 HIV protease inhibitors 750 0.198
37110 Thrombin inhibitors 803 0.180
31432 Angiotensin II AT1 antagonists 943 0.229
42731 Substance P antagonists 1246 0.149
06233 Substance P antagonists 752 0.140
06245 5HT reuptake inhibitors 359 0.122
07701 D2 antagonists 395 0.138
06235 5HT1A agonists 827 0.133
78374 Protein kinase C inhibitors 453 0.120
78331 Cyclooxygenase inhibitors 636 0.108
Table 2: MDDR activity classes for DS2 dataset.
Activity
index Activity class Active
molecules
Pairwise
similarity
(mean)
07707 Adenosine (A1) agonists 207 0.229
07708 Adenosine (A2) agonists 156 0.305
31420 Renin inhibitors 1 1300 0.290
42710 CCK agonists 111 0.361
64100 Monocyclic-lactams 1346 0.336
64200 Cephalosporins 113 0.322
64220 Carbacephems 1051 0.269
64500 Carbapenems 126 0.260
64350 Tribactams 388 0.305
75755 Vitamin D analogous 455 0.386
where n = the number of the unique fragments assigned to
reference structure r.
2.3. BINRF Model. The diﬀerence between the two models
(BIN and BINRF) arises from the diﬀerences in the type
of belief function used to produce the ranking of the
compounds in the collection. In the conventional BIN
model, the probability of the reference node is computed by
summing the probabilities in the fragment nodes connected
to the reference node. The fragment nodes participating in
the ﬁnal probability are scored equally (meaning that no
extra weight given to any fragment node). This calculation
is conducted using the SUM operator, as described above.
In the BINRF model, the reweighting factor is used to
assign a new weight to the fragment. In order to produce this
factor, it is necessary to start by analysing the occurrence of
each fragment in the set of input references. The reweighing
factor rwfi is calculated using (4):
rwfi =
Ffi
maxF
,( 4 )
Table 3: MDDR activity classes for DS3 dataset.
Activity
index Activity class Active
molecules
Pairwise
similarity
(mean)
09249 Muscarinic (M1) agonists 900 0.111
12455 NMDA receptor antagonists 1400 0.098
12464 Nitric oxide synthase inhibitors 505 0.102
31281 Dopamine-hydroxylase
inhibitors 106 0.125
43210 Aldose reductase inhibitors 957 0.119
71522 Reverse transcriptase inhibitors 700 0.103
75721 Aromatase inhibitors 636 0.110
78331 Cyclooxygenase inhibitors 636 0.108
78348 Phospholipase A2 inhibitors 617 0.123
78351 Lipoxygenase inhibitors 2111 0.113
where Ffi is the frequency of ith fragment in the set of
references’ input and maxF is the maximum fragment
frequency in the set of references’ input.
New weights are then assigned to the fragments based on
this factor, the new weight, nwi, of the ith fragment, is given
by (5):
nwi = wi +rwfi,( 5 )
where wi is the original frequency of the ith fragment in the
reference input.
Consequently, the use of (4)a n d( 5) to assign the new
weights shows that higher weights will be assigned to those
that occur more frequently in the set of references’ input
structures.
2.4. Experimental Design. The searches were carried out on
the MDL Drug Data Report (MDDR) database. The 102,516
molecules in the MDDR database were converted to Pipeline
Pilot ECFC 4 ﬁngerprints and folded to give 1024-element
ﬁngerprints [28].
For the screening experiments, three data sets (DS1–
DS3) [29] were chosen from the MDDR database. Dataset
DS1 contains 11 MDDR activity classes, with some of the
classes involving actives that are structurally homogeneous
and others involving actives that are structurally heteroge-
neous (structurally diverse). The DS2 dataset contains 10
homogeneous MDDR activity classes and the DS3 dataset
contains 10 heterogeneous MDDR activity classes. Full
details of these datasets are given in Tables 1–3.E a c hr o wi n
the tables contains an activity class, the number of molecules
belonging to the class, and the class’s diversity, which
was computed as the mean pair-wise Tanimoto similarity
calculated across all pairs of molecules in the class using
ECFP6. The pair-wise similarity calculations for all datasets
were performed using Pipeline Pilot software [28].
For each dataset (DS1–DS3), the screening experiments
were conducted with 10 reference structures selected ran-
domly from each activity class and the similarity measure
used to obtain an activity score for all of its compounds.4 The Scientiﬁc World Journal
Table 4: The recall is calculated using the top 1% and top 5% of the DS1 data sets when ranked using the TAN, BIN, and BINRF.
Activity index
1% 5%
TAN BIN BINRF TAN BIN BINRF
31420 55.84∗ 74.08∗ 81.8∗∗ 85.49∗ 87.61∗∗ 84.12∗
71523 22.26∗ 28.26∗ 43.86∗∗ 42.7∗ 52.72∗ 68.72∗∗
37110 12.54∗ 26.05∗ 41.25∗∗ 24.11∗ 48.2∗ 71.05∗∗
31432 33.36∗ 39.23∗ 46.5∗∗ 68.2∗ 77.57∗ 91.59∗∗
42731 16.24∗ 21.68∗ 28.13∗∗ 32.81∗ 26.63∗ 42.39∗∗
06233 14.23∗ 14.06∗ 16.75∗∗ 27.01∗ 23.49∗ 32.93∗∗
06245 10.06∗∗ 6.31∗ 10.04∗ 22.9∗ 14.86∗ 28.8∗∗
07701 8.91∗ 11.45∗ 19.75∗∗ 23.1∗ 27.79∗ 41.24∗∗
06235 11.87∗ 10.84∗ 12.45∗∗ 24.54∗ 23.78∗ 31.89∗∗
78374 16.75∗ 14.25∗ 25.49∗∗ 24.26∗ 20.2∗ 39.18∗∗
78331 8.05∗ 6.03∗ 8.14∗∗ 16.83∗∗ 11.8∗ 11.20∗
Mean 19.10 22.93 30.38 35.63 37.69 49.73
Share cells 1 0 10 1 1 9
Table 5: The recall is calculated using the top 1% and top 5% of the DS2 data sets when ranked using the TAN, BIN, and BINRF.
Activity index
1% 5%
TAN BIN BINRF TAN BIN BINRF
07707 78.3∗∗ 72.18∗ 72.33∗ 91.08∗∗ 74.81∗ 74.17∗
07708 74.01∗ 96∗ 100∗∗ 88.52∗ 99.61∗ 100∗∗
31420 46.44∗ 79.82∗ 82.71∗∗ 77.6∗ 95.46∗ 97.15∗∗
42710 57.22∗ 76.27∗ 95.36∗∗ 67.59∗ 92.55∗ 99.36∗∗
64100 93.22∗ 88.43∗∗ 87.75∗ 97.89∗ 99.22∗∗ 98.93∗
64200 63.39∗ 70.18∗ 71.79∗∗ 89.82∗ 99.2∗∗ 99.12∗
64220 73.56∗ 68.32∗ 82.47∗∗ 92.05∗ 91.32∗ 98.89∗∗
64500 60.75∗ 81.2∗ 96.56∗∗ 74.98∗ 94.96∗ 99.28∗∗
64350 76.69∗ 81.89∗ 93.67∗∗ 90.34∗ 91.47∗ 98.24∗∗
75755 95.99∗ 98.06∗ 98.26∗∗ 98.78∗∗ 98.33∗ 98.33∗
Mean 71.957 81.235 88.09 86.86 93.69 96.34
Share cells 1 1 8 2 2 6
These activity scores were then sorted in descending order
with the recall of the active compounds, meaning the
percentage of the desired activity class compounds that are
retrieved in the top 1% and 5% of the resultant sorted
activity scores, providing a measure of the performance of
our similarity method.
3. Results andDiscussion
Our goal was to identify diﬀerent retrieval eﬀectiveness of
using diﬀerent search approaches. In this study, we tested the
TAN, BIN, and BINRF models against the MDDR database
using three diﬀerent datasets (DS1–DS3). The results of the
searchesofDS1–DS3arepresentedinTables4-6,respectively ,
using cutoﬀs at both 1% and 5%.
In these tables, the ﬁrst column from the left contains
the results for the TAN, the second column contains the
corresponding results when BIN is used, and the last column
ofeachtablecontainsthecorrespondingresultswhenBINRF
is used.
Each row in the tables lists the recall for the top 1% and
5% of a sorted ranking when averaged over the ten searches
for each activity class; and the penultimate row in each table
corresponds to the mean value for that similarity method
when averaged over all of the activity classes for a dataset.
The similarity method with the best recall rate in each row
is strongly (∗∗), and the recall value is boldfaced; any
similarity method with an average recall within 1% and 5%
of the value for the best similarity method is shown lightly
(∗) . The bottom row in a table corresponds to the total
number of (∗ and ∗∗) cells for each similarity method
across the full set of activity classes.
VisualinspectionoftherecallvaluesinTables4–6enables
c o m p a ri s o n st ob em a d eb e t w e e nt h ee ﬀectiveness of the var-
ious search models. However, a more quantitative approach
is possible using the Kendall W test of concordance [30].
This test shows whether a set of judges make comparable
judgments about the ranking of a set of objects; here, the
activityclasseswereconsideredthejudgesandtherecallratesThe Scientiﬁc World Journal 5
Table 6: The recall is calculated using the top 1% and top 5% of the DS3 data sets when ranked using the TAN, BIN, and BINRF.
Activity index
1% 5%
TAN BIN BINRF TAN BIN BINRF
09249 25.09∗∗ 15.33∗ 15.51∗ 40.21∗∗ 25.72∗ 29.08∗
12455 7.7∗ 9.37∗ 11.59∗∗ 19.08∗∗ 14.65∗ 16.77∗
12464 9.02∗ 8.45∗ 11.67∗∗ 14.56∗ 16.55∗ 27.1∗∗
31281 27.53∗ 18.29∗ 44.48∗∗ 44∗ 28.29∗ 59.9∗∗
43210 11.1∗∗ 7.34∗ 9.41∗ 26.37∗∗ 14.41∗ 21.27∗
71522 2.35∗ 4.08∗ 11.39∗∗ 6.28∗ 8.44∗ 23.62∗∗
75721 24.02∗ 20.41∗ 28.24∗∗ 28.97∗ 30.02∗ 56.39∗∗
78331 6.27∗ 7.51∗ 10.11∗∗ 15.79∗ 12.03∗ 18.82∗∗
78348 4.69∗ 9.79∗∗ 8.99∗ 13.16∗ 20.76∗ 24.15∗∗
78351 4.31∗ 13.68∗ 16.64∗∗ 10.55∗ 12.94∗ 20.16∗∗
Mean 12.21 11.42 16.80 21.90 18.38 29.72
S h a r e c e l l s217307
Table 7: Rankings of weighting functions based on Kendall W test
results: DS1–DS3 Top 1% and 5%.
Dataset Recall type WP Ranking
DS1 1% 0.75 <0.01 BINRF > BIN > TAN
5% 0.71 <0.01 BINRF > TAN > BIN
DS2 1% 0.39 >0.01 BINRF > BIN > TAN
5% 0.28 <0.01 BINRF > BIN > TAN
DS3 1% 0.37 <0.01 BINRF>TAN>BIN
5% 0.39 <0.01 BINRF>TAN>BIN
of the various search models the objects. The outputs of this
test are the value of the Kendall coeﬃcient and the associated
signiﬁcance level, which indicates whether this value of the
coeﬃcient could have occurred by chance. If the value is
signiﬁcant (for which we used cutoﬀ values of both 0.01 and
0.05), then it is possible to give an overall ranking of the
objects that have been ranked. The results of the Kendall
analyses (for DS1–DS3) are reported in Table 7 and describe
the top 1% and top 5% rankings for the various weighting
functions. In Table 7, the columns show the dataset type, the
recall percentage, the value of the coeﬃcient, the associated
probability, and the ranking of the methods.
Some of the activity classes, such as low-diversity activity
classes, may contribute disproportionally to the overall value
of mean recall. Therefore, using the mean recall value as the
evaluation criterion could be impartial in some methods but
notinothers.Toavoidthisbias,theeﬀectiveperformancesof
the diﬀerent methods have been further investigated based
on the total number of (∗ and ∗∗) cells for each method
across the full set of activity classes, as shown in the bottom
rows of Tables 4–6. These (∗ and ∗∗) cell results are also
listed in Table 8 (the results shown in the bottom rows of
Tables 4–6 form the lower part of the results in Table 8).
InspectionoftheDS1searchinTable 4 showsthatBINRF
produced the highest mean values when compared to the
BIN and TAN. In addition, according to the total number
of (∗ and ∗∗)c e ll si nTable 4, BINRF is the best performing
Table 8: Number of (∗ and ∗∗) cells for mean recall of actives
using diﬀerent search models for DS1–DS3 Top 1% and 5%.
Dataset TAN BIN BINRF
Top 1%
DS1 1 0 10
D S 2 118
D S 3 217
Top 5%
D S 1 119
D S 2 226
D S 3 307
search across the 11 activity classes in terms of mean recall.
Table 7 shows that the value of the Kendall coeﬃcient for
DS1 top 1% and 5%, 0.752, is signiﬁcant at the 0.01 and
0.05 levels of statistical signiﬁcance. Given that the result is
signiﬁcant, we can conclude that the overall ranking of the
diﬀerent procedures are BINRF > BIN > TAN and BINRF >
TAN > BIN for the DS1 top 1% and 5%, respectively.
The good performance of the BINRF method is not
restricted to DS1 since it also gives the best results for the
top 1% and 5% for DS2 and DS3.
The DS3 searches are of particular interest since they
involve the most heterogeneous activity classes in the three
datasets used, and thus provide a tough test of the eﬀec-
tiveness of a screening method. Hert et al. [29] found that
TSS (group fusion) was not preferred to the conventional
similarity search for DS3 activity classes. However, when
BINRF is used on this dataset, Tables 6 and 7 show that it
gives the best performance of all the methods for this dataset
at both cutoﬀs.
Visual inspection of the results in Tables 4–8 shows very
clearly that reweighting reference fragments can signiﬁcantly
increase the eﬀectiveness of the BIN method and the results
are presented for the original search using TAN, BIN, and
BINRF. A very surprising pattern of behaviour is observed
in the DS3 results presented in Table 6 as the degree of6 The Scientiﬁc World Journal
enhancement in this more challenging screening task is
remarkable.
In conclusion, we have introduced a new technique for
utilisingtheeﬀectivenessofretrievalwhenapplyingaBINfor
ligand-based virtual screening. Simulated virtual screening
experiments with MDDR datasets showed that the proposed
techniques described here provide simple ways of enhancing
the cost eﬀectiveness of ligand-based virtual screening in
chemical databases.
4. Conclusion
In this paper, we further investigated the impact of reweight-
ing fragments on the Bayesian inference network perfor-
mance for ligand-based virtual screening. Simulated virtual
screening experiments with MDL Drug Data Report datasets
showed that the proposed approach signiﬁcantly improved
the retrieval eﬀectiveness of ligand-based virtual screening,
especially when the active molecules being sought had a high
degree of structural heterogeneity. This ﬁnding is in line
with our previous study, in which the relevance feedback
information was used to reweight the fragments. However,
it should be pointed out that while using relevance feedback
informationislimitedonlybycomputationalcost,usingaset
ofreferencestructuresimpliestheavailabilityofbioactivities.
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